 |
|
Penn researchers gain new insights on spinal muscular atrophy
May 30, 2008PHILADELPHIA - Researchers from the University of Pennsylvania School of Medicine discovered that the effect of a protein deficiency, which is the basis of the neuromuscular disease spinal muscular atrophy (SMA), is not restricted to motor nerve cells, suggesting that SMA is a more general disorder. This new insight will allow for better understanding of how this complex disease arises. Gideon Dreyfuss, PhD, the Isaac Norris Professor of Biochemistry and Biophysics and Investigator, Howard Hughes Medical Institute and colleagues, report their findings in last week's issue of Cell.
SMA is a group of hereditary diseases that causes weakness and wasting of the voluntary muscles in the arms and legs of infants and children. The disorders are a result of genetic lesions in a gene called survival of motor proteins (SMN) that cause a deficiency in the SMN protein. This protein is essential for all cells, but reduced levels of SMN cause spinal muscular atrophy. Why this seemingly cell-specific reduction happens is not known.
SMN normally works in all cells to bring small RNAs together with specific proteins to form particles called snRNPs (pronounced snurps). snRNPs are the molecular machines that splice different parts of RNA together to form the messenger RNA (mRNA) before it leaves the nucleus to travel to the cytoplasm. Here, mRNAs get translated into working proteins.
"SMN plays a key role in determining the inventory of the different types of snRNPs in all cells, what we call the snRNP repertoire or the 'snRNPertoire,'" says Dreyfuss. "When SMN levels are reduced, the biochemical balance needed to make the snRNP complexes for splicing RNA is impaired."
The Dreyfuss lab looked at reduced SMN levels in cultured cells and mice and found that changes in levels of the snRNPs, as well as the mRNAs - their spliced products - were affected, producing numerous abnormal mRNAs. These effects varied from tissue to tissue. The findings suggest that spinal muscular atrophy is a general disease of splicing.
"Now we know that SMA is clearly a disease that not only affects motor neurons, but all cell types when the gene for SMN is damaged," says Dreyfuss. In the end, concludes Dreyfuss, this is a different way to look at the disease. Finding a way to restore SMN levels in the entire body is one therapeutic approach to aim for, based on these findings.
University of Pennsylvania School of Medicine
"SMN plays a key role in determining the inventory of the different types of snRNPs in all cells, what we call the snRNP repertoire or the 'snRNPertoire,'" says Dreyfuss. "When SMN levels are reduced, the biochemical balance needed to make the snRNP complexes for splicing RNA is impaired."
The Dreyfuss lab looked at reduced SMN levels in cultured cells and mice and found that changes in levels of the snRNPs, as well as the mRNAs - their spliced products - were affected, producing numerous abnormal mRNAs. These effects varied from tissue to tissue. The findings suggest that spinal muscular atrophy is a general disease of splicing.
"Now we know that SMA is clearly a disease that not only affects motor neurons, but all cell types when the gene for SMN is damaged," says Dreyfuss. In the end, concludes Dreyfuss, this is a different way to look at the disease. Finding a way to restore SMN levels in the entire body is one therapeutic approach to aim for, based on these findings.
University of Pennsylvania School of Medicine
Spinal Muscular Atrophy Current Events and Spinal Muscular Atrophy News RSSCold Spring Harbor Laboratory Scientists Devise Potential Approach To Treat Spinal Muscular Atrophy
In the neuromuscular disease called spinal muscular atrophy, or SMA, a protein deficiency caused by a single gene mutation leads to serious damage in growing nerve cells and the muscles they control.
CSHL shows correcting rna splicing may help treat spinal muscular atrophy
RNA splicing antisense technology studied at Cold Spring Harbor Laboratory (CSHL) effectively corrected an mRNA splicing defect found in spinal muscular atrophy (SMA) patients, and is now ready to be tested in mouse models.
Treatment extends survival in mouse model of spinal muscular atrophy
Drug therapy can extend survival and improve movement in a mouse model of spinal muscular atrophy (SMA), new research shows. The study, carried out at the NIH's National Institute of Neurological Disorders and Stroke (NINDS), suggests that similar drugs might one day be useful for treating human SMA.
Drug blocks lethal motor-neuron disease in mice
Spinal muscular atrophy (SMA) is an inherited motor-neuron disease that, in its most severe form, leads to death before 2 years of age and for which there is no treatment.
Genetic variation: We're more different than we thought
New research shows that at least 10 percent of genes in the human population can vary in the number of copies of DNA sequences they contain-a finding that alters current thinking that the DNA of any two humans is 99.9 percent similar in content and identity.
Epilepsy drug eases symptoms of inherited disorder that weakens muscles
An epilepsy drug that has been on the market for decades can ease the symptoms of adult sufferers with a genetic disorder that seriously weakens muscles.
Neurons grown from embryonic stem cells restore function in paralyzed rats
For the first time, researchers have enticed transplants of embryonic stem cell-derived motor neurons in the spinal cord to connect with muscles and partially restore function in paralyzed animals.
'Smart' genetic therapy helps the body to heal itself
New approaches to genetic disease, based on cells' own ability to correct themselves, will be outlined today (Monday 8 May 2006) at the annual conference of the European Society of Human Genetics in Amsterdam, The Netherlands.
Neurological disease raises risk of complications from flu
As another flu season approaches, patients with neurological and neuromuscular disease are especially vulnerable to respiratory failure caused by influenza.
Scientists discover possible new treatment for genetic diseases
Scientists from Imperial College London, the University of Leicester, and Hammersmith Hospital have found a way to stop certain types of genetic diseases from occurring by modifying the way DNA is turned into proteins. The research published in this month's Proceedings of the National Academy of Science shows how the researchers have been able to restore proper expression of defective genes, and that this might potentially have a positive effect in genetic diseases such as spinal muscular atrophy. The research was carried out at Imperial College London and the University of Leicester as a collaboration between Professor Francesco Muntoni and Professor Ian Eperon. Professor Muntoni, from
More Spinal Muscular Atrophy Current Events and Spinal Muscular Atrophy News Articles
 | The Official Parent's Sourcebook on Spinal Muscular Atrophy: A Revised and Updated Directory for the Internet Age by Icon Health Publications This book has been created for parents who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells parents where and how to look for information covering virtually all topics related to spinal muscular atrophy (also Infantile Spinal Muscular Atrophy, Type I;... |
 | Spinal Muscular Atrophy - A Bibliography and Dictionary for Physicians, Patients, and Genome Researchers by Philip M. Parker In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing.... |
 | Living with Spinal Muscular Atrophy: The True Story of Kassidy Jade Sears by Trina Allen Kassidy was born into the world just months prior to the soon to be roller-coaster ride her young parents would face. Kassidy was the only child and the only grandchild at this time, which seemed healthy and happy. Such devastating news would soon follow the day she turned three months old. The strength and courage that Kassidy had will never be forgotten. The love that this little girl had for... |
 | Spinal Muscular Atrophy Medical Guide by Qontro Medical Guides The Spinal Muscular Atrophy Medical Guide is a publication which has been designed to better help readers understand Spinal Muscular Atrophy. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Spinal Muscular Atrophy. The Spinal Muscular Atrophy Medical Guide is highly recommended for those... |
| Spinal Muscular Atrophy: Infantile and Juvenile Type; by Irena Hausmanowa-; Petrussewicz | |
| Current Concepts in Childhood Spinal Muscular Atrophy by L. Merlini, C. Granata | |
| Spinal muscular atrophy: An entry from Thomson Gale's Gale Encyclopedia of Children's Health: Infancy through Adolescence by Rosalyn, MD Carson-DeWitt Avoiding hard-to-understand medical jargon, the four-volume “Gale Encyclopedia of Children’s Health” uses language that parents can understand, while still providing enough depth to benefit today's health science students. The set provides in-depth coverage of pediatric diseases and disorders, along with issues related to physical and cognitive/behavioral... | |
| Spinal muscular atrophy: Infantile and juvenile type by Irena Hausmanowa-Petrusewicz | |
| Spinal muscular atrophy: An entry from Thomson Gale's Gale Encyclopedia of Neurological Disorders by Borut, MD, PhD Peterlin Targeted to patients, their families and allied health students, The “Gale Encyclopedia of Neurological Disorders” provides in-depth coverage of neurological diseases and disorders, including stroke, multiple sclerosis, Parkinson disease, Tourette Syndrome, Alzheimer's disease, cerebral palsy, vertigo, amnesia and epilepsy. Related topics include communication aids, electric personal... | |
| Spinal muscular atrophy: An entry from Thomson Gale's Gale Encyclopedia of Genetic Disorders, 2nd ed. by Philip Young, Christian, PhD Lorson Information on many genetic disorders, and the frequent new findings on them, has been extremely difficult to come by—until now. The “Gale Encyclopedia of Genetic Disorders” addresses the need for current, hard-to-find facts on emerging discoveries. The two-volume Encyclopedia, presented in a single alphabetical sequence, provides clear, complete information on genetic disorders, including... |
| © 2008 BrightSurf.com |